kdc/one and Clarion Group Announce Major Production and Packaging Joint Venture in Fast-Emerging Indian Market
Industry Leaders to Leverage Complementary Expertise and Industry-Leading Capabilities, Develop New Manufacturing…
Ever Joint Benefits: How This Supplement Supports Flexibility and Weight Loss
TALLMADGE, Ohio, March 22, 2025 (GLOBE NEWSWIRE) -- Weight management remains a…
Primera for Women: Natural Ingredients for Bladder Control & Pelvic Wellness
NASHVILLE, Tenn., March 22, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced world,…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
IBM and L’Oral to Build First AI Model to Advance the Creation of Sustainable Cosmetics
PARIS and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- IBM (NYSE: IBM)…
DARZALEX (daratumumab) subcutaneous formulation shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smouldering multiple myeloma
First subcutaneous anti-CD38 therapy to demonstrate potential to prevent end-organ damage, and…